RECALL RECORD — CLASS IIRecall closedF-0798-2023/FDA enforcement

Prosante Tsoyflr 7p Mncd 25lb Bg/40p, Prosante Tsoyflr 7p Mncd 50lb Bg, 25 lb and 50lb Paper…

What you need to know

Class II
  • What happened

    Products with a gluten free claim may contain gluten levels above 20 ppm.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall closed · classified by the FDANationwide (US)More food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameCargill, INC Corporate Headquarters
Recalling firmCargill, INC Corporate HeadquartersWayzata, MN, United States
UPC / barcodes
10 000141 10232 310 000141 10382 310 000141 10402 310 000141 10712 310 000141 10722 310 000141 12832 210 000141 13042 210 000141 13052 210 000141 13212 210 000141 13222 210 000141 13322 210 000141 13462 2
Lot / date codes
  • 100001411-02323CHXEA 100001411-03823CHXEA 100001411-04023CHXEA 100001411-07123CHXEA 100001411-07223CHXEA 100001411-28322CHXEA 100001411-30422CHXEA 100001411-30522CHXEA 100001411-32122CHXEA 100001411-32222CHXEA 100001411-33222CHXEA 100001411-34622CHXEA 100001411-34722CHXEA 100001412-32122CHXEA
Distribution area
Nationwide

Nationwide United States, Canada, Chile, Costa Rica, Guatemala, Mexico, and United Kingdom

United States, Canada, Mexico, United Kingdom

Quantity affected641, 675 lbs
Recall initiationFDA report date: May 10, 2023
FDA recall numberF-0798-2023

Beyond the headline

The recall, in context

Cargill, INC Corporate Headquarters initiated this food recall on March 30, 2023. The FDA enforcement report states: Products with a gluten free claim may contain gluten levels above 20 ppm. The FDA report lists distribution as: Nationwide United States, Canada, Chile, Costa Rica, Guatemala, Mexico, and United Kingdom.

The FDA enforcement report describes the reason as: Products with a gluten free claim may contain gluten levels above 20 ppm.

Prosante Tsoyflr 7p Mncd 25lb Bg/40p, Prosante Tsoyflr 7p Mncd 50lb Bg, 25 lb and 50lb Paper… was made or distributed by Cargill, INC Corporate Headquarters in Wayzata, MN, United States. This page reflects FDA report F-0798-2023, dated May 10, 2023.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared wheat or gluten

Symptoms to watch for

Wheat allergy can cause hives, nausea, cramps, breathing difficulty or anaphylaxis. For celiac disease, even small amounts of gluten can cause intestinal damage.

When symptoms may appear

Allergic reactions can begin within minutes to hours. Celiac-related intestinal effects may be delayed.

Higher-risk groups

People with wheat allergy, celiac disease, non-celiac gluten sensitivity or a history of anaphylaxis.

What to do now

  1. 1Do not eat the product if you have a wheat allergy or must avoid gluten.
  2. 2Seek emergency care for breathing difficulty or other signs of a severe allergic reaction.
  3. 3Keep the packaging and contact the retailer or manufacturer about a refund.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Prosante Tsoyflr 7p Mncd 25lb Bg/40p, Prosante Tsoyflr 7p Mncd 50lb Bg, 25 lb and 50lb Paper… recall?

Cargill, INC Corporate Headquarters recalled Prosante Tsoyflr 7p Mncd 25lb Bg/40p, Prosante Tsoyflr 7p Mncd 50lb Bg, 25 lb and 50lb Paper… in an FDA Class II enforcement action reported as F-0798-2023. Products with a gluten free claim may contain gluten levels above 20 ppm.

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Do not eat the product if you have a wheat allergy or must avoid gluten. Seek emergency care for breathing difficulty or other signs of a severe allergic reaction. Keep the packaging and contact the retailer or manufacturer about a refund.

Is the Cargill, INC Corporate Headquarters recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0798-2023. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Cargill, INC Corporate Headquarters

View brand

Related alerts

Recent Other safety concern recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.